Scott E. Evans

Dr. Evans is a physician-scientist at the University of Texas MD Anderson Cancer Center. A pulmonary medicine expert with a specialized interest in pneumonia, he runs an NIH-funded laboratory that investigates innate immune responses in the lungs. Work in Dr Evans’ laboratory lead to the discovery of Pulmotect’s lead compound, PUL-042. His team remains focused on exploring the mechanisms that underlie inducible resistance, in order to efficiently harness the remarkable protection associated with this phenomenon.